Did you mean aprd00160 of aprd00309 of aprd00416?
Displaying all 3 drugs
Levodopa
Levodopa is a prodrug of dopamine that is administered to patients with Parkinson's due to its ability to cross the blood-brain barrier[Label]. Levodopa can be metabolised to dopamine on either side of the blood-brain barrier and so it is generally administered with a dopa decarboxylase inhibitor like carbidopa to prevent...
Approved
Matched Mixtures name: … LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 …
Entacapone
Entacapone is a selective, reversible catechol-O-methyl transferase (COMT) inhibitor for the treatment of Parkinson's disease. It is a member of the class of nitrocatechols. When administered concomittantly with levodopa and a decarboxylase inhibitor (e.g., carbidopa), increased and more sustained plasma levodopa concentrations are reached as compared to the administration of...
Approved
Investigational
Matched Mixtures name: … LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 …
Carbidopa
Carbidopa presents a chemical denomination of N-amino-alpha-methyl-3-hydroxy-L-tyrosine monohydrate. It potently inhibits aromatic amino acid decarboxylase (DDC) and due to its chemical properties, it does not cross the blood-brain barrier. Due to its activity, carbidopa is always administered concomitantly with levodopa. An individual formulation containing solely carbidopa was generated to treat...
Approved
Matched Mixtures name: … LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 …
Displaying all 3 drugs